Dr. Jerry Klein gives the need-to-know information about using CBD oil to treat dogs. Learn what CBD oil is, what it does, side effects, and. And just as CBD has helped humans, your dog can reap the same health- boosting (and even CBD (cannabidiol) is a compound found in cannabis and hemp. So here's our recommendation on the best CBD dog treat product.
Treatment For Dogs CBD
Twenty-two client-owned dogs with clinically and radiographically confirmed evidence of osteoarthritis were recruited. Sixteen of these dogs completed the trial and were included in the analyses; their breed, weight, age, sex, worse affected limb, radiographic findings, use of NSAIDs and sequence of treatments are summarized in Table 2.
Characteristics of dogs enrolled in a placebo-controlled study investigating the effects of CBD on osteoarthritis. No other veterinary pain comparisons were statistically significant. No changes were observed in weight-bearing capacity when evaluated utilizing the veterinary lameness and pain scoring system Table 3.
Canine Brief Pain Inventory Pain and Activity questions and Hudson Scale mean and standard deviation; lameness, weight-bearing and pain scores median and ranges at each time for cannabidiol CBD and placebo oils.
Chemistry analysis and CBC were performed at each visit. No significant change in the measured CBC values was noted in either the CBD oil or placebo treated dogs data not shown.
Other notable significances in serum chemistry values were associated with primarily age or NSAID use. Box-and-whisker plot of serum alkaline phosphatase ALP activity at each time for treatment and placebo oils. Box represents the mean and 25th and 75th percentile and the whiskers represent the 99th and 1st percentiles.
To date, an objective evaluation of the pharmacokinetics of a commercially available industrial hemp product after oral dosing in dogs is absent.
This half-life was shorter than a previous report after intravenous 1. In the intravenous study, CBD distribution was rapid, followed by prolonged elimination with a terminal half-life of 9 h. This may be due to the first pass effect in the liver, and the product was not in an oil base, but a powder within a gelatin capsule being a different delivery vehicle Although our dogs were fasted the delivery vehicle was olive oil which is a food item.
The absorption may be greater and more consistent because of the oil-based vehicle which may be due to the lipophilic nature of CBD, hence delivery with food may be preferable 32 , As previously demonstrated, CBD biotransformation in dogs involves hydroxylation, carboxylation and conjugation, leading to relatively rapid elimination suggesting a more frequent dosing schedule The dosing schedule of twice per day was chosen due to the practical nature of this dosing regimen even though the elimination is well within a three or four time a day dosing regimen.
Our hope was that the lipophilic nature of CBD would allow for a steady state over time, and future studies examining 24 h pharmacokinetics with different dosing regimens with larger numbers of dogs, and steady state serum pharmacokinetics after extended treatment in a clinical population are sorely needed.
The main objective of this study was to perform an owner and veterinary double-blinded, placebo-controlled, cross-over study to determine the efficacy of CBD oil in dogs affected by OA. Additionally, veterinary assessments of pain were also favorable. Although a caregiver placebo effect should be considered with subjective evaluations by owners and veterinarians 35 , the cross-over design limits confounding covariates since each dog serves as its own control. Our statistical model controlled for the possible effect of treatment sequence.
The lack of a placebo effect in our study may be due to nine of the 16 owners being intimately involved in veterinary medical care, all of whom have an understanding of the placebo effect making them more cognizant of improvements when providing feedback. In addition, there was a noticeable decrease in Hudson scores and rise in CBPI scores during the initiation placebo treatment suggesting a potential carry over effect of CBD treatment indicating that a longer washout period might be indicated in future studies.
This carry over effect may have resulted in some improved perceptions at the initiation of the placebo treatment which were eliminated by week 4 of placebo treatment, underscoring the importance of longer term steady state PK studies in dogs. There was no significant difference in subjective veterinary lameness score and weight-bearing capacity throughout the study. Kinetic data was obtained from these dogs data not shown , however 11 of the 16 dogs had significant bilateral disease stifle, coxofemoral, or elbow making evaluation of peak vertical force or symmetry tenuous at best.
Unilateral disease in any of the aforementioned joints would be ideal to study the kinetic effects of this or similar extracts for pain relief leading to better objective outcomes. The population we used in our investigation was representative of dogs presenting in a clinical setting for management of OA and represents the typical OA patient.
Currently, NSAIDs are the primary treatment for OA and are associated with negative effects on the gastrointestinal tract and glomerular filtration 2.
In the current study, no significant difference was noted in BUN, creatinine, or phosphorus between dogs treated with the CBD oil vs. A mild rise in creatinine from baseline was noted in both groups at weeks 2 and 4, the hydration status of the dogs was unknown; however changes in albumin sodium, and chloride were unchanged suggesting euhydration, and all creatinine values remained within the reference interval.
Increased ALP activity is fairly sensitive for hepatobiliary changes in this age group, but not specific. Increased ALP activity noted in nine dogs in the CBD treatment group may be an effect of the hemp extract attributed to the induction of cytochrome p mediated oxidative metabolism of the liver reported previously with prolonged exposure to cannabis 36 — Other causes of cholestasis, increased endogenous corticosteroid release from stress, or a progression of regenerative nodular hyperplasia of the liver cannot be ruled out.
Without concurrent significant rise in ALT in the CBD treatment to support hepatocellular damage, or biopsy for further clarification, the significance is uncertain. As such, it may be prudent to monitor liver enzyme values especially ALP while dogs are receiving industrial hemp products until controlled long term safety studies are published.
A recent survey reported that pet owners endorse hemp based treats and products because of perceived improvement in numerous ailments, as hemp products were moderately to very helpful medicinally Some of the conditions thought to be relieved by hemp consumption were: One immunohistochemical study suggested that cannabinoids could protect against the effects of immune-mediated and inflammatory allergic disorders in dogs 40 whereas another uncontrolled study suggested that CBD has anticonvulsant and anti-epileptic properties in dogs There were some dogs with incidental rises in alkaline phosphatase that could be related to the treatment.
Further long-term studies with larger populations are needed to identify long-term effects of CBD rich industrial hemp treatment, however short term effects appear to be positive. L-JG was responsible for data analysis and interpretation, drafting of the manuscript and approval of the submitted manuscript. JB was responsible for the conception of the study and manuscript writing and revisions.
CF was responsible for acquisition of data and manuscript revision. WS was responsible for pharmacokinetic evaluation and revision of the manuscript. SM was responsible for statistical analysis, data analysis and revision of the manuscript. LW was responsible for laboratory work including liquid chromatography-mass spectrometry.
HB was responsible for interpretation of the blood work and manuscript revision. EB was responsible for acquisition of data, and data analysis. JW was responsible for the conception of study, supervised data collection, statistical analysis, and manuscript editing.
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The authors would like to thank Renee C. Staffeld and Danny Sack for data entry. Clinical pharmacology of nonsteroidal anti-inflammatory drugs in dogs. J Am Anim Hosp Assoc. Systematic review of nonsteroidal anti-inflammatory drug-induced adverse effects in dogs.
J Vet Intern Med. Evaluation of adverse effects of long-term oral administration of carprofen, etodolac, flunixin meglumine, ketoprofen, and meloxicam in dogs. Am J Vet Res. The endocannabinoid system and its therapeutic exploitation. Nat Rev Drug Discov. Non-psychoactive cannabinoids modulate the descending pathway of antinociception in anaesthetized rats through several mechanisms of action. Cannabinoid receptor localization in brain.
Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations. CB2 receptors in the brain: Characterisation of the cannabinoid receptor system in synovial tissue and fluid in patients with osteoarthritis and rheumatoid arthritis. Rapaka RS, Makriyannis, A, editors. Struct-Activ Relationsh Cannabin Zhornitsky S, Potvin S.
Cannabidiol in humans - the quest for therapeutic targets. The nonpsychoactive component of marijuana cannabidiol modulates chemotaxis and IL and IL production of murine macrophages both in vivo and in vitro. Vanilloid TRPV1 receptor mediates the antihyperalgesic effect of the nonpsychoactive cannabinoid, cannabidiol, in a rat model of acute inflammation. Antihyperalgesic effect of a Cannabis sativa extract in a rat model of neuropathic pain: Continuous intrathecal infusion of cannabinoid receptor agonists attenuates nerve ligation—induced pain in rats.
Reg Anesth Pain Med. Antinociceptive effect of intrathecal cannabinoid receptor agonist WIN 55, in a rat bone tumor pain model. The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis. J Pharm Biomed Anal. A novel microflow LC-MS method for the quantitation of endocannabinoids in serum.
Shrivastava A, Gupta VB. Methods for the determination of limit of detection and limit of quantitation of the analytical methods. Power of treatment success definitions when the Canine Brief Pain Inventory is used to evaluate carprofen treatment for the control of pain and inflammation in dogs with osteoarthritis.
Ability of the canine brief pain inventory to detect response to treatment in dogs with osteoarthritis. J Am Vet Med Assoc. Assessing repeatability and validity of a visual analogue scale questionnaire for use in assessing pain and lameness in dogs. A randomized controlled trial of the efficacy of autologous platelet therapy for the treatment of osteoarthritis in dogs. Applying multigroup confirmatory factor models for continuous outcomes to likert scale data complicates meaningful group comparisons.
Carifio J, Perla R. Ten common misunderstandings, misconceptions, persistent myths and urban legends about likert scales and likert response formats and their antidotes.
The CBD oil did wonders for both my dogs. Throughout this article, I will be discussing what CBD is, how it works, what the benefits are, and all the questions you may have about the ground-breaking substance.
Cannabidiol CBD is a substance that is found in a cannabis or hemp plant. You may be interested to know that both humans and dogs have the same endogenous cannabinoid system.
CBD acts by targeting these receptors located in the brain, organs, central nervous system, and immune cells that stimulate relaxing effects. The benefits of using CBD for your dog is incredible, with more and more people seeking the treatment for their furry friends.
Products containing this substance have opened up a whole new world for pet care and those who believe in natural remedies. Many dog owners turn to CBD when their canine suffers from seizures and epilepsy.
Over time, it has been known to reduce the frequency of them, and in some cases get rid of the seizures altogether. Arthritis is the inflammation of joints that cause aching, pain, and other degenerative illnesses. As CBD is a pain reliever, it targets these aching joints and gives your dog relief. Not only that, but it soothes the chronic inflammation that prevents your pet from healing properly. When a dog loses their appetite, it can be hard to know the reason why.
Majority of the time, however, they lose it due to nausea. CBD can do this for your pet. If you have ever suffered from anxiety, then you know that it is awful, and it would be the same for your dog too. Many dogs suffer from anxiety and have been known to be depressed and extremely anxious in certain situations, such as when their owner leaves.
This can result in destructive behaviors such as chewing objects, urinating, pacing, and more. CBD helps because it is a relaxing stimulant that calms your pet. Unfortunately, dogs can get cancer too, and when they do they have symptoms of nausea, loss of appetite, and chronic pain. CBD allows your pet to feel comfortable during those difficult times and helps to reduce the side effects that cancer can have on your dog. Pet owners are also giving their dogs small doses of CBD daily as it has been proven to aid in preventing and killing cancer by:.
The majority of diseases in dogs all result in the same types of symptoms — chronic pain, nausea, loss of appetite, change in behavior, etc. CBD is an all-around stimulant that can help your dog relax and alleviate pain in troubling times. When thinking about CBD for your dog, you should first understand the difference between marijuana and hemp. Firstly, they both come from the same cannabis sativa plant, however, have different properties and results.
Marijuana — is the buds, leaves, and resin of the cannabis plant and are a high source of a substance called tetrahydrocannabinol THC. Hemp — is the rest of the plant. Whilst the tincture and the oil are great, you may find that the dog treats work better for your dog as they are more prone to want to take the treat. Find out what dog treats we recommend below. CBD products are absolutely safe for your dog as they are non-toxic and offers a relaxing stimulant and pain-relief effects.
Cannabinoids come from the hemp oil or hemp seed oil and leave out most if not all of the THC making it a safe supplement for your pet. No, CBD products are not a psychoactive agent, meaning that they do not contain the substance THC that causes this reaction. Marijuana comes from the hemp plant Cannabis sativa with the active ingredient THC, but CBD is a relaxant and pain-relief agent and non-psychotropic. We have created a list of the best brands for selling CBD oil for dogs below:.
It comes in three formulas. Pain Relief , Health Restore , and Calming. Therabis — focuses on calm quiet. Zesty Paws — focuses primarily on calming bites. Hemp Chewz — focuses on joint pain. Honest Paws also has a great support team willing to answer any and all of your questions. And better yet, you can reach them right on your Facebook messenger.
Marijuana plants contain 80 different cannabinoids, Shu says, including THC ( tetrahydrocannabinol, the psychoactive component) and CBD (cannabidiol, the. Below I'll take a brief look at cancer, how it affects dogs, and how it is traditionally treated. Then I'll reveal how CBD can potentially help dogs with cancer. Things to Consider When Treating Your Pet With CBD. Before we look at the specifics about CBD dosage for dogs, it's important to cover some basics.